Navigation Links
Hoosiers Work for Health Highlights Impact of Medical Research and Innovation on Indiana Economy

INDIANAPOLIS, March 26 /PRNewswire/ -- A coalition of Indiana's leaders in research, medicine, public health, education, labor and business joined today to launch Hoosiers Work for Health ( to stress the importance of preserving medical innovation. Co-chairs, former Indianapolis Mayor Bart Peterson, and the President of the Pacers Sports & Entertainment Jim Morris, kicked off the effort at the Indiana Statehouse.

Hoosiers Work for Health will highlight the importance of biopharmaceutical research and innovation on Indiana's economy. The partnership includes local chambers of commerce, research centers, labor, businesses, patient advocacy organizations, provider groups and biopharmaceutical sector employees who work to provide a better quality of life to all Hoosiers. Hoosiers Work for Health will focus on providing information and educating Hoosiers about the sector and how it affects them.

Today's kickoff will initiate an aggressive, statewide education effort, focused on bringing Hoosiers together on the issues of healthcare access, provision and innovation. Our partners will hold informational meetings, health fairs and industry site visits to assure that all Hoosiers understand the impact of the life sciences sector in Indiana and how best to assure it continues to grow here at home.

"Hoosiers Work for Health was created to highlight its partners' dedication to innovation, research and development of new cures; their contributions to state and local philanthropic causes; and their far-reaching presence as an economic force," said co-chair, Jim Morris. "Our partners support policies that recognize the value of innovation and take steps to preserve and foster America's ability to innovate."

Hoosiers Work for Health is one of ten state chapters of We Work for Health, a national effort that is the driving force behind improving health care for millions of Americans and strengthening local and regional economies. This network seeks to demonstrate to federal policymakers, key opinion leaders and the media the need for strong public policy to promote innovation and, along with it, the health of Hoosiers and the economy.

"Many of the companies involved in the biopharmaceutical industry in Indiana also provide philanthropic outreach in local communities through grants and programs, supporting access to affordable health coverage and medicine, primary and secondary education, social services, arts and other community needs," said Bart Peterson, co-chair of Hoosiers Work for Health. "Our partners significantly contribute to the overall economic strength of the Indiana communities in which they are involved. By creating jobs, providing growth opportunities for related industries, fostering higher education in science and math, and generating tax revenue, this network creates a strong foundation that will help to provide stability and prosperity in the future."

In conjunction with today's kickoff rally at the Indiana Statehouse, Hoosiers Work for Health released a new economic study underscoring the biopharmaceutical industry's impact on Indiana's economy.

The new economic study, entitled The Biopharmaceutical Sector's Impact on the U.S. Economy: Analysis at the National, State, and Local Levels, was conducted by Archstone Consulting and Dr. Lawton R. Burns, Director, The Wharton Center for Health Management and Economics at The Wharton School, University of Pennsylvania, and was commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA) to evaluate the impact of this research-intensive industry.

The study showed that the presence of biopharmaceutical companies, and the jobs they support, make substantial contributions to state economies. By acting as a magnet for bioscience investment, biopharmaceutical companies in Indiana help transform our state and regional economy by drawing highly educated labor, attracting and enhancing research and educational institutions and industry.

  • Economic output represents the value of goods and services produced by the sector and its ripple effects. In 2006, the Indiana biopharmaceutical sector supported $22.7 billion in total output.
  • Direct biopharmaceutical wages in Indiana were estimated to be $1.4 billion in 2006, resulting in an estimated $350.3 million in federal taxes and $43.3 million in state taxes.
  • Biopharmaceutical companies supported a total of 89,763 jobs in Indiana in 2006 - 15,306 directly in the sector and 74,457 in other sectors.

"Despite an extremely difficult economic environment, the life sciences industry remains a valuable component to Indiana's economy through its contribution of highly skilled and high-paying jobs, indirect job creation, and significant expenditure on the research and development that fosters innovation," said John C. Lechleiter, Ph.D., chairman, president and CEO Eli Lilly and Company. "Just as important, Indiana's life sciences industry is making a difference for Hoosiers and for people worldwide, helping them to live better, more productive, and longer lives."

Lechleiter added, "As citizens in these challenging times, we need to encourage our political leaders to fix what is broken - but we also need to make sure we don't break what still works. Today, innovation in the life sciences is one of those things that still works."

A separate analysis by PhRMA, the results of which were released simultaneously, found that domestic research and development investment by PhRMA members accounted for roughly 70 percent of all R&D spending in 2008. The survey found that pharmaceutical research and biotechnology companies invested a record $65.2 billion in 2008, a roughly $2 billion increase over 2007. PhRMA member investment reached a record $50.3 billion, a nearly 5 percent increase over 2007.

Michael Eckstut, Principal and Life Sciences and Strategy Practice Leader, Archstone Consulting, commented, "Our research indicates that the biopharmaceutical sector has made a substantial contribution to U.S. economic growth, and that on average, this sector contributed more to GDP on a per employee basis and grew faster than the rest of the economy from 1996 to 2006."

In addition, the local presence of the biopharmaceutical industry has a job multiplier effect, supporting an even greater number of American jobs, the Archstone study found.

About Hoosiers Work for Health

Hoosiers Work for Health is the Indiana chapter of a national initiative that unites health consumers, biopharmaceutical company employees, vendors, suppliers and other business and community partners to demonstrate how these diverse groups are vital to the socioeconomic climate and provide shared benefits and a better quality of life to all. Specifically, the partnership includes local chambers of commerce and research centers, labor, businesses, patient advocacy organizations, provider groups and biopharmaceutical research companies that work together to improve America's health care system and strengthen our economy. More information is available

Contact: Michael O'Connor, Hoosiers Work for Health, (317) 684-5473

SOURCE Hoosiers Work for Health
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Prime Health Network and Its Patients Thrive in Tough Economic Times on the InstaMed Network
2. TeleHealth Services and Lakeland HealthCare Connect to Create Outstanding Patient Experience
3. The NIHR Biomedical Research Centre for Mental Health London has Joined the MetaMiner CNS Partnership Program
4. New Online Imaging Suite Boosts Healthcare Imaging Efficiency, Productivity, and Revenues
5. RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference
6. Healthcare Institutions Can Now Stay Confidently Up-to-Date With New Regulatory Compliance Calendar
7. Gundersen Lutheran Health System is Recognized for Safe Lifting Leadership
8. Amgen to Present at the Cowen and Company Annual Healthcare Conference
9. RoundTable Healthcare Partners Facilitates Product Acquisition for CorePharma
10. PDHI Launches Short Form of Its ConXus Profile Health Assessment
11. Novavax to Present at Cowen and Company 29th Annual Healthcare Conference
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... ... systems, material handling solutions and components, is opening its latest Parker Store retail ... the facility is Exotic’s second major expansion in Metropolitan Detroit in less than ...
(Date:10/13/2015)... Charlotte, NC (PRWEB) , ... October 13, 2015 ... ... high intensity focused ultrasound (HIFU) technologies, announced today that it received de novo ... 450 in the U.S. for the ablation of prostate tissue. Sonablate® is ...
(Date:10/13/2015)... WHITEHOUSE, New Jersey (PRWEB) , ... October 13, ... ... designed to enhance the educational opportunities for school age children in the areas ... are essential for all sectors of the national economy, and the program aims ...
(Date:10/12/2015)... and BRUSSELS , Oct. 12, 2015 ... UCB) today presented additional findings from an exploratory sub-study of ... findings were presented today in an oral plenary session at ... Annual Meeting in Seattle . ... --> The small exploratory sub-study data showed that, at ...
Breaking Biology Technology:
(Date:10/12/2015)... Research and Markets ( ) ... Recognition Market by Component (Hardware & Software), Product ... Industry (Travel & Immigration, Military & Defense, & ... report to their offering. ... Market worth 3627.90 Million USD by 2020 ...
(Date:10/7/2015)... 8, 2015 --> ... Cards (FPC) during third quarter 2015 amounted to around 960 ... 860 MSEK that was communicated 20 August 2015. ... delivery capacity and a continued growing demand for the company,s ... to be higher than during the third quarter. The revenue ...
(Date:10/2/2015)... ) has ... Law Using Biometrics" report to their offering. ... addition of the "Enforcing the Law Using ... Research and Markets ( ) has ... Law Using Biometrics" report to their offering. ...
Breaking Biology News(10 mins):